Advanced molecular test can improve diagnosis of a genetic form of COPD

National Jewish Health researchers with the Advanced Diagnostic Laboratories have developed a molecular diagnostic test capable of accurately diagnosing a major genetic cause of chronic obstructive pulmonary disease (COPD) known as Alpha-1 Antitrypsin Deficiency (AATD).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup